Ablynx is a biopharmaceutical company that engages in the discovery and development of Nanobodies for the small-molecule drug applications... Read more
Ablynx is a biopharmaceutical company that engages in the discovery and development of Nanobodies for the small-molecule drug applications... Read more
CEO
Add
News
Jul 15, 2021
MarketScreener
Ablynx N.V.: LabGenius : Announces Research Collaboration With Ablynx, a Sanofi Company
Jun 12, 2020
European Biotechnology
Ablynx: Ablynx takes Phase III hurdle in acquired TTP
Feb 05, 2020
Zolmax News
Ablynx: Contrasting Ablynx (OTCMKTS:ABLYF) & Tcr2 Therapeutics (OTCMKTS:TCRR)
Dec 23, 2019
Zolmax News
Ablynx: Head-To-Head Survey: Ablynx (OTCMKTS:ABLYF) vs. MeiraGTx (OTCMKTS:MGTX)
Feb 07, 2019
BioPharma-Reporter
Ablynx: Sanofi nanobody drug first approved to treat rare blood disorder
Sep 03, 2018
StreetInsider
Press Release: Ablynx : Sanofi: Cablivi(TM) (caplacizumab) approved in Europe for adults with acquired thrombotic thrombocytopenic purpura (aTTP)
Jul 27, 2018
BioPortfolio
Ablynx: Ablynx NV ABLX Financial and Strategic SWOT Analysis Review Report Updated 20062018 Prices from USD $125
Jul 08, 2018
BioPortfolio
Ablynx: Ablynx raises US$230m
Jun 20, 2018
PharmaTech
Ablynx: Sanofi Completes $4.8-Billion Ablynx Acquisition
May 25, 2018
GlobalNewswire
Press Release: Ablynx : NOTICE IN RELATION TO THE CONVERTIBLE BONDS DUE MAY 2020
Ablynx N.V. Competitors
1
2
3
4
5
6
7
8
9
10